Posted 9/15/2023, 7:11:51 AM
Sandoz Aims to Become Top Biosimilars Maker With 5 New Launches
- Sandoz plans to launch at least 5 more biologic drugs ahead of its market debut
- It currently has 25 biosimilars in its pipeline, aiming for 30
- Sandoz wants to overtake Pfizer as the top biosimilars maker
- New product launches in U.S. and Europe key to reaching growth and margin goals
- Major deals not on the agenda, existing infrastructure can handle launches
- Biosimilars currently 20% of sales, but key to boosting profitability
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7HFY6IYSZNIJ3DYLTAP7DWT2NQ.jpg)